(Reuters) - President Donald Trump is facing pressure from U.S. hospitals and generic drugmakers to exempt medical goods from ...

We recently published a list of 15 Stocks That Took a Nosedive in January. In this article, we are going to take a look at ...

Now that the year is underway and a new presidential administration is in place in Washington, let’s consider the environment ...

Fidson Healthcare Plc, a top pharmaceutical company in Nigeria, has appointed three new directors in a move to bolster its ...

Morgan Stanley analyst Jeffrey Hung maintained a Buy rating on Ultragenyx Pharmaceutical (RARE – Research Report) today and set a price target ...

January 2025 kicked off with a wave of impactful biotech deals, setting the stage for an exciting year of innovation.

Pharma giant AstraZeneca urged Britain to improve the environment for businesses in order to drive investment, days after it ...

Pfizer and Merck, ostensibly beleaguered drugmakers, have seen their shares battered despite reporting strong earnings.

A pharmaceutical company has secured 10,000sq ft of office space at Maxis Business Park in Bracknell, Berkshire. The deal, ...

Any tariffs on India or potential onshoring in US would be counterproductive, increasing the prices for US generics created ...

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Skye Bioscience (SKYE – Research Report), Eton ...

Labcorp forecast 2025 revenue above Wall Street estimates after reporting fourth-quarter results beat on Thursday, banking on ...